Searchable abstracts of presentations at key conferences in endocrinology

ea0092op-09-01 | Oral Session 9: Thyroid Eye Disease | ETA2023

VRDN-001, a full antagonist antibody to IGF-1 receptor: in vitro pharmacology and phase 1/2 results in patients with thyroid eye disease (TED)

Douglas Raymond , Ugradar Shoaib , Turbin Roger , Cockerham Kimberly , Tang Rosa , Nijhawan Navdeep , Kossler Andrea , Boisvert Chantal , Lee Wendy , Yen Michael , Kaufman David , Yoon Michael , Bedian Vahe , Katz Barrett

Objectives: Antagonism of the IGF-1 receptor (IGF-1R) has been shown to reduce TED-related inflammation and proptosis. VRDN-001, a high-affinity antagonist antibody to IGF-1R, has distinct pharmacological properties that may enable differentiated dosing and better efficacy than observed with other antibodies. We assessed VRDN-001 in vitro pharmacology compared with teprotumumab and clinical proof of concept in a phase 1/2 randomized controlled trial (NCT05176639)....

ea0099p120 | Pituitary and Neuroendocrinology | ECE2024

Approaching the reality of restoring GH secretion and growth with the investigative oral growth hormone secretagogue (GHS) LUM-201 in moderate pediatric growth hormone deficiency (PGHD)

Clayton Peter , Cassorla Fernando , Trial Group OraGrowtH210 , Trial Group OraGrowtH212 , Johnson Michael , Bruchey Aleksandra , Smith Christopher , Brincks Erik , ' Duke' Pitukcheewanot Pisit , McKew John , Thorner Michael

Over 40 years ago, the first enkephalin analogs that stimulated growth hormone (GH) release were synthesized in 1984, leading to the development of GHRP-6. In 1995, Merck developed a potent non-peptide orally active long-acting growth hormone GHS, ibutamoren, and cloned the GHS receptor in 1996, which led to ghrelin being identified as its natural ligand in 1999. These discoveries uncovered a new physiological pathway for GH regulation linking the GI tract and the hypothalamic...

ea0077p79 | Neuroendocrinology and Pituitary | SFEBES2021

MRI bone shape in patients with acromegaly: a novel technique for the characterisation of the acromegalic arthropathy

Kyriakakis Nikolaos , Bowes Michael , Lynch Julie , Kingsbury Sarah , Orme Steve , Murray Robert , Conaghan Philip

Objective: Arthropathy is the commonest morbidity in acromegaly and the main determinant of quality of life in these patients. Most of current knowledge is derived from studies using conventional x-rays. This study aims to characterise acromegalic arthropathy using modern imaging techniques.Methods: Case control study comprising of 60 acromegaly patients (29 males, mean age 54.8± 12.9yrs) and 300 age/gender-matched controls from the publicly availab...

ea0077p104 | Reproductive Endocrinology | SFEBES2021

An exploration of the association between CAG repeat status and mortality in men

Heald Adrian , Cook Michael , Javed Ahmed , Fachim Helene , O’Neill Terence , Wu Fred

Introduction: The androgen receptor (AR) mediates the peripheral effects of testosterone. The main mechanism of action for the AR is direct regulation of gene transcription. Available evidence suggests that the number of CAG repeats in exon-1 of the AR gene is negatively correlated with transcriptional activity of the AR and that CAG repeat number links to mortality rate in T2DM men. The aim of this analysis was to determine the association between CAG repeat number and all ca...

ea0055wd2 | Workshop D: Disorders of the thyroid gland (II) | SFEEU2018

An unusual route to the diagnosis of medullary thyroid cancer

Gilroy Michael , Redford Christopher , Dunn Julie , Patel Amita , Kyrodimou Efstathia , Baple Emma , Flanagan Daniel , Vaidya Bijay

We describe a 68 year lady who was found to have bilateral adrenal masses (7 cm on the right side and 1.3 cm on the left) during investigations for gastrointestinal symptoms, in early 2016. Biochemistry revealed high urinary normetanephrines of 41.7pmol/24h (ref 0–3) and metanephrines of 40pmol/24h (ref 0–1.8). A PET and MIBG scan revealed uptake in both adrenals and therefore a diagnosis of bilateral phaeochromocytoma was made. The patient had complained of occasion...

ea0054is8 | (1) | NuclearReceptors2018

Direct and indirect effects of androgens on the musculoskeletal system

Claessens Frank , Michael Laurent , Dubois Vanessa , Khalil Rougin , Jardi Ferran , Vanderschueren Dirk

Global knockout models of the androgen receptor (ARKO) illustrates the many roles androgens and their receptor have in the development of male reproductive organs and the gender differences in many features like the musculoskeletal system. However, neither the global ARKO nor orchidectomy models discriminate between direct and indirect effects of androgens. To determine direct and indirect effects of androgens on muscle, we developed a muscle-specific ARKO (called satARKO for ...

ea0051oc4.1 | Oral Communications 4 | BSPED2017

Patients with self-limited delayed puberty harbour mutations in multiple genes controlling GnRH neuronal development

Howard Sasha , Andre Valentina , Guasti Leo , Cabrera Claudia , Barnes Michael , Cariboni Anna , Dunkel Leo

Objectives: Abnormal pubertal timing affects >4% of adolescents and is associated with adverse health outcomes. Up to 80% of variation in the timing of pubertal onset is genetically determined. Self-limited delayed puberty (DP) segregates in an autosomal dominant pattern, but in the majority the neuroendocrine pathophysiology and genetic regulation remain unclear. Mis-regulation of the embryonic migration of GnRH neurons has been implicated in the pathogenesis of DP (Howar...

ea0051p029 | Miscellaneous/other | BSPED2017

Bisphosphonate therapy in Williams-Beuren syndrome: case series

Maduemem Kene , Kennedy Elaine , Morrissey Rose , Riordan Michael , O'Riordan Stephen M P

Introduction: Hypercalcaemia in Williams-Beuren syndrome (WBS) is usually mild and transient, but may be severe in about 5% of new presentations. Often some children will not respond well to traditional therapies.Case report: We describe three cases of acute hypercalcaemia and their management in a regional Paediatric unit. Case 1: A 16-month-old known WBS girl, presented with irritability, reduced feeding. Corrected serum calcium was 4.51 mmol/l. She wa...

ea0081p148 | Pituitary and Neuroendocrinology | ECE2022

AZP-3813, a bicyclic 16-amino acid peptide antagonist of the human growth hormone receptor as a potential new treatment for acromegaly

Milano Stephane , Kurasaki Haruaki , Tomiyama Tatsuya , Reid Patrick , Jan Van der Lely Aart , Culler Michael D.

Medical treatment of acromegaly is based on either suppressing pituitary GH secretion or inhibiting GH action by preventing interaction with its receptor in order to suppress the elevated levels of IGF1. AZP-3813 is a 16-amino acid, bicyclic peptide antagonist of the GH receptor (GHR) derived from peptide sequences discovered using a unique, cell-free in vitro transcription-translation system screened against the human GHR, and that was optimized by rational design to increase...

ea0081p449 | Reproductive and Developmental Endocrinology | ECE2022

Global impact of PCOS awareness month: challenges and opportunities

Malhotra Kashish , Synn Cuen Pan Carina , Davitadze Meri , Manolopoulos Konstantinos , O'Reilly Michael , Arlt Wiebke , Kempegowda Punith

Background: September is celebrated as PCOS awareness month worldwide and is aimed at improving the lives of those with PCOS, promoting research, and strengthening advocacy efforts. While significant financial and human resources are invested in promotions during this month, to the best of our knowledge, there is no evidence to show the impact of this initiative. In our study, we evaluated the global digital impact of PCOS Awareness Month, tracking commonly used hashtags as su...